Prescient Completes Equity Raising to Raise $9.1 Million
Filed with ASX ·
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
In the deck
Earlier from Prescient Therapeutics
- December 2018 Appendix 4C - Quarterly
- Interim Durability Analysis of PTX-200 Breast Cancer Study
- September 2018 Appendix 4C - Quarterly
- Pipeline Collaboration for Next Generation Formulations
- Change of Registry Address: Automic P/L - Sydney Office
Later from Prescient Therapeutics
- Capital Raising Presentation - March 2019
- Prospectus
- Despatch of Entitlement Offer Documents
- March 2019 Appendix 4C - Quarterly
- Entitlement Offer Results and Shortfall Notification
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics